# US 2025/0152650 A1 · Compositions for treating sea lice in salmon and related methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0152650 A1
- Document ID: US20250152650A1
- Status: Published application
- Kind: A1
- Application number: 18/947,873
- Filed: 2024-11-14
- Published: 2025-05-15
- Earliest claimed: 2023-11-14
- Assignees: Kemin Industries, Inc.
- Applicants: Kemin Industries, Inc.
- Inventors: Mukkalil Rajalekshmi; Koenraad Frans Leon Meynen
- Web page: https://patentgrep.com/patent/US20250152650A1

## CPC

- A61K 36/534: Mentha (mint)
- A61K 31/05: Phenols {(cannabinoids A61K31/658)}
- A61K 31/122: having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K 36/53: Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K 36/71: Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61P 33/14: Ectoparasiticides, e.g. scabicides
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to compositions to treat sea lice in salmon, where such compositions do not impose safety hazards to aquatic life. According to one aspect, the present invention relates to methods of treating sea lice in salmon by administering a composition for treating sea lice in salmon, wherein the composition comprises monarda oil, alone or in combination with oregano oil with elevated levels of thymol, and optionally comprising one or more plant-based essential oil, where there is a synergistic effect with the combination of thymol and thymoquinone, and further where the composition is administered in an amount effective to treat copepodid stage and mobile staged sea lice. Another aspect of the present invention relates to a method of reducing copepodid and mobile-staged salmon lice activity by administering compositions containing an effective amount of monarda oil and oregano oil with elevated levels of thymol, alone or in combination with other plant-derived essential oils.

## Claims

### Claim 1

A method of treating sea lice in salmon by administering a composition comprising an extract of monarda in an amount effective to reduce the number of the sea lice attached to the salmon.

### Claim 2 (depends on 1)

The method of claim 1, wherein the composition comprises monarda oil in an amount effective to reduce the number of the sea lice attached to the salmon.

### Claim 3 (depends on 1)

The method of claim 1, wherein the composition further comprises an extract of oregano.

### Claim 4 (depends on 1)

The method of claim 1, wherein the composition further comprises an extract of oregano oil with thymol present in an amount of about 40% or more.

### Claim 5 (depends on 1)

The method of claim 1, wherein the composition comprises one or more plant-based essential oil.

### Claim 6 (depends on 35)

The method of claim 35, wherein the one or more plant-based essential oil is selected from the group consisting of monarda oil, oregano oil and nigella oil.

### Claim 7 (depends on 1)

The method of claim 1, wherein the composition is orally administered to the salmon.

### Claim 8 (depends on 1)

The method of claim 1, wherein the composition is topically administered to the salmon.

### Claim 9

A method of treating sea lice in salmon by administering a composition comprising thymoquinone in an amount effective to upregulate wound healing gene expression or reduce the number of the sea lice attached to the salmon.

### Claim 10 (depends on 69)

The method of claim 69, wherein the thymoquinone is derived from one or more plant-based essential oil.

### Claim 11 (depends on 69)

The method of claim 69, wherein the thymoquinone is derived from monarda or nigella.

### Claim 12 (depends on 19)

The method of claim 19, wherein the composition further comprises an extract of oregano oil with thymol present in an amount of about 40% or more.

### Claim 13 (depends on 19)

The method of claim 19, wherein the composition comprises one or more plant-based essential oil selected from the group consisting of monarda oil, oregano oil and nigella oil.

### Claim 14 (depends on 69)

The method of claim 69, wherein the composition is orally administered to the salmon.

### Claim 15 (depends on 69)

The method of claim 69, wherein the composition is topically administered to the salmon.

### Claim 16

A method of reducing copepodid and mobile-staged salmon lice activity by administering compositions containing an effective amount of monarda oil and oregano oil with elevated levels of thymol.

### Claim 17 (depends on 1116)

The method of claim 1116, wherein the composition further comprises one or more plant-derived essential oils.

### Claim 18 (depends on 116)

The method of claim 116, wherein the composition further comprises an extract of oregano oil with thymol present in an amount of about 40% or more.

### Claim 19 (depends on 1116)

The method of claim 1116, wherein the composition is orally administered to the salmon.

### Claim 20 (depends on 1116)

The method of claim 1116, wherein the composition is topically administered to the salmon.
